Pharmacovigilance Study To Evaluate Safety Of SERETIDE Administration In Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Recruitment status was Active, not recruiting
Primary objective: Evaluation of the safety of Seretide discus administration in subjects with COPD. Treatment duration: 2 years. Study has 3 phases: Screening phase (visit 1), treatment phase (visits 2-5. In the case of AE, there will be another visit (visit 6) as a follow up visit - follow up phase.
Chronic Obstructive Pulmonary Disease (COPD)
|Study Design:||Time Perspective: Prospective|
|Official Title:||A Pharmacovigilance Study to Evaluate Safety of Seretide 50/500µg Administered Twice Daily Through the Discus Device, for 104 Weeks, to Subjects With COPD|